Your shopping cart is currently empty

MAT2A-IN-10 (Compound 28), an orally active inhibitor of MAT2A, exhibits an IC50 of 26 nM and is utilized in cancer research [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $1,370 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $2,780 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $3,700 | 8-10 weeks | 8-10 weeks |
| Description | MAT2A-IN-10 (Compound 28), an orally active inhibitor of MAT2A, exhibits an IC50 of 26 nM and is utilized in cancer research [1]. |
| In vitro | MAT2A-IN-10 (Compound 28; 0.1 nM-10 μM; 4 days) inhibits the proliferation of HCT-116 (MTAP-/-) cells with an IC50 of 75 ± 5 nM, without affecting HCT-116 (WT) cells [1]. |
| In vivo | MAT2A-IN-10 (Compound 28; orally administered once daily for 6 days) induced tumor regression in the HCT-116 (MTAP-/-) mouse xenograft model [1]. |
| Molecular Weight | 534.51 |
| Formula | C27H24F2N6O4 |
| Cas No. | 2924825-23-8 |
| Smiles | O=C1N(C=2C(C(=O)N1C=3C=C4N5C(=NC4=CC3)CN(C)CC5)=CC=C(OCC)N2)C6=CC=C(OC(F)F)C=C6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.